glp-1 and thyroid disease Implications of Receptor Agonist on Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality TSH Levels GLP-1 Receptor Agonists: A Promising
Description
Studies have shown Lillys dual GIP and GLP-1 receptor agonist has advantages, including greater weight loss, over Novos single-acting GLP-1 drug
By contrast, people who switched to a placebo pill regained about 20 pounds (lb) after six months
FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes. Tirzepatide for weight loss: Lilly: Investors (2022)
Final Thoughts GLP-1 side effects are common at the start of treatment but are usually mild and temporary
